Marianne Hald Clemmensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marianne Hald Clemmensen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Joo Hanne Poulsen
The Hospital Pharmacy Research Unit, University Hospital Sønderjylland, 6200 Aabenraa, Denmark
4 shared publications - Lotte Stig Nørgaard
Department of Pharmacy, University of Copenhagen , Universitetsparken 2, 2100 Copenhagen
3 shared publications Anders Hay-Schmidt
Department of Neuroscience and Pharmacology, University of Copenhagen, Denmark
2 shared publicationsJens D. Mikkelsen
Department of Neuroscience and Pharmacology, University of Copenhagen, Denmark
2 shared publicationsAnn Kathrin Demény
Affiliation Emergency Department, Capital Region of Denmark, Bispebjerg Hospital, Copenhagen NV, Denmark
1 shared publication- Carmen Sandi
Laboratory of Behavioral Genetics, Brain Mind Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne
1 shared publication
Latest Publications
- 1 January 2024
- Published by SPL Publishing in Sygeplejevidenskab.dk - Journal of Nursing Research & Professional Knowledge
Patientperspektiv ved skift i injektionsbehandling i reumatologiske ambulatorier
Resumé Introduktion Præparatskift forårsaget af forsyningsvanskeligheder udfordrer patientsikkerheden og kan føre til medicineringsfejl og hospitalsindlæggelser. Præparatskift skaber forvirring og usikkerhed blandt sundhedsprofessionelle og patienter, som ofte udtrykker bekymring ved præparatskift, især ved tilbagevendende symptomer og bivirkninger. Praktiske udfordringer som fx synkeproblemer eller ændringer i injektionsmedicin kan påvirke compliance. Sundhedsprofessionelle spiller en vigtig rolle i at sikre patientsikkerheden gennem patientuddannelse og kontinuitet i pleje. Formål Studiet formål er at undersøge patienters erfaringer med præparatskift og behovet for information og støttende initiativer ved skifte i injektionsbehandlinger, som selvadministreres i eget hjem. Metode Fire fokusgruppeinterviews blev gennemført online og fysisk med ni patienter, som har erfaring med præparatskift af subkutane injektioner. Data blev analyseret ved hjælp af en tematisk netværksanalyse. Resultater Fire hovedtemaer blev identificeret: 1) Behov for forberedelse ved skift af injektionsmedicin. 2) Tryghed ved ny injektionsmedicin 3) Informationskilde ved skift i injektionsmedicin. 4) Økonomisk perspektiv. Konklusion Patienter ønsker mundtlig information om præparatskift ved sygeplejekonsultationer, og sygehusapotekerne kan støtte ambulatorierne ved at sikre rettidig information om præparatskift. Demonstrationsenheder er vigtige for patientsikkerheden, da de giver patienterne mulighed for at øve sig i håndteringen og administrationen af et nyt præparat i patientsikre omgivelser. Medicinalleverandører opfordres til at levere disse ved licitationsprocessen. Keywords: Præparatskift i injektionsmedicin, patientperspektiv, sygeplejekonsultationer, patienttryghed, demonstrationsdevice, selvadministration, patientsikkerhed, licitationsskift.
- 1 January 2024
- Published by SPL Publishing in Sygeplejevidenskab.dk - Journal of Nursing Research & Professional Knowledge
Patientperspektiv ved skift i injektionsbehandling i reumatologiske ambulatorier
Resumé Introduktion Præparatskift forårsaget af forsyningsvanskeligheder udfordrer patientsikkerheden og kan føre til medicineringsfejl og hospitalsindlæggelser. Præparatskift skaber forvirring og usikkerhed blandt sundhedsprofessionelle og patienter, som ofte udtrykker bekymring ved præparatskift, især ved tilbagevendende symptomer og bivirkninger. Praktiske udfordringer som fx synkeproblemer eller ændringer i injektionsmedicin kan påvirke compliance. Sundhedsprofessionelle spiller en vigtig rolle i at sikre patientsikkerheden gennem patientuddannelse og kontinuitet i pleje. Formål Studiet formål er at undersøge patienters erfaringer med præparatskift og behovet for information og støttende initiativer ved skifte i injektionsbehandlinger, som selvadministreres i eget hjem. Metode Fire fokusgruppeinterviews blev gennemført online og fysisk med ni patienter, som har erfaring med præparatskift af subkutane injektioner. Data blev analyseret ved hjælp af en tematisk netværksanalyse. Resultater Fire hovedtemaer blev identificeret: 1) Behov for forberedelse ved skift af injektionsmedicin. 2) Tryghed ved ny injektionsmedicin 3) Informationskilde ved skift i injektionsmedicin. 4) Økonomisk perspektiv. Konklusion Patienter ønsker mundtlig information om præparatskift ved sygeplejekonsultationer, og sygehusapotekerne kan støtte ambulatorierne ved at sikre rettidig information om præparatskift. Demonstrationsenheder er vigtige for patientsikkerheden, da de giver patienterne mulighed for at øve sig i håndteringen og administrationen af et nyt præparat i patientsikre omgivelser. Medicinalleverandører opfordres til at levere disse ved licitationsprocessen. Keywords: Præparatskift i injektionsmedicin, patientperspektiv, sygeplejekonsultationer, patienttryghed, demonstrationsdevice, selvadministration, patientsikkerhed, licitationsskift.
- Open Access
- 26 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0293523
Medicine information helpline after hospitalization–a randomized trial: Impact on patient satisfaction, patient concerns about medicines and clinical outcome on patient safety
Background and aim: Hospitalization often leads to changes in patients’ medicine which challenges a safe medication use after discharge. Medicine information helplines (MIHs) can be valuable for patients in overcoming these challenges. This study evaluates patient satisfaction with a newly established Danish hospital-based MIH for discharged patients. The MIH is operated by experienced pharmacists and a pharmacy technician, and the study explores how the service affects the patient’s concerns and perception of safety in relation to their medication, followed by an assessment of the clinical impact of MIH on patient safety. Method: A randomized controlled study design was used in the present study. The study was registered at clinicaltrials.gov with the identification number NCT03829995. Participants were randomized 1:4 (50:200) into a control- and intervention group. Participants in the control group were offered standard care and those in the intervention group were offered access to the MIH. A telephone interview performed 2–4 weeks after discharge assessed patient satisfaction with the helpline and patient’s feeling of safety in relation to medicine use (primary outcome). Data were analyzed using a Mann-Whitney U test. After case handling of each enquiry to the MIH, the cases were assessed with regard to medication-related problems (MRPs) and clinical impact of the MIH service was assessed (primary outcome). Results: A total of 250 participants were included in the study and 152 participated in the telephone interviews (33 control and 119 intervention). Thirty-seven questions were enquired by 26 participants to the MIH. Of these, 8 were requested before the telephone interviews and these patients all expressed a high satisfaction with the MIH (score 4.57 +/- 0.73 on a 5-point scale). Most patients offered access to the MIH expressed that it increased the sense of safety in relation to their medicines (79%). However, comparing the control- and intervention group with regard to patient concerns and feeling of safety in relation to medicine use no differences were found. Evaluation of the enquiries revealed at least one MRP per enquiry, and in most cases the advice given were assessed to have a high- or moderate clinical significance. Conclusion: The MIH was appreciated by the participants, indicating that the MIH could be a valuable service for discharged patients in improving the sense of safety in relation to medication and alleviating MRPs. Providing easy access for patients to medicine information may contribute to patient safe medicine use after discharge.
- 26 October 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (10) , e0293523
Open AccessMedicine information helpline after hospitalization–a randomized trial: Impact on patient satisfaction, patient concerns about medicines and clinical outcome on patient safety
Background and aim: Hospitalization often leads to changes in patients’ medicine which challenges a safe medication use after discharge. Medicine information helplines (MIHs) can be valuable for patients in overcoming these challenges. This study evaluates patient satisfaction with a newly established Danish hospital-based MIH for discharged patients. The MIH is operated by experienced pharmacists and a pharmacy technician, and the study explores how the service affects the patient’s concerns and perception of safety in relation to their medication, followed by an assessment of the clinical impact of MIH on patient safety. Method: A randomized controlled study design was used in the present study. The study was registered at clinicaltrials.gov with the identification number NCT03829995. Participants were randomized 1:4 (50:200) into a control- and intervention group. Participants in the control group were offered standard care and those in the intervention group were offered access to the MIH. A telephone interview performed 2–4 weeks after discharge assessed patient satisfaction with the helpline and patient’s feeling of safety in relation to medicine use (primary outcome). Data were analyzed using a Mann-Whitney U test. After case handling of each enquiry to the MIH, the cases were assessed with regard to medication-related problems (MRPs) and clinical impact of the MIH service was assessed (primary outcome). Results: A total of 250 participants were included in the study and 152 participated in the telephone interviews (33 control and 119 intervention). Thirty-seven questions were enquired by 26 participants to the MIH. Of these, 8 were requested before the telephone interviews and these patients all expressed a high satisfaction with the MIH (score 4.57 +/- 0.73 on a 5-point scale). Most patients offered access to the MIH expressed that it increased the sense of safety in relation to their medicines (79%). However, comparing the control- and intervention group with regard to patient concerns and feeling of safety in relation to medicine use no differences were found. Evaluation of the enquiries revealed at least one MRP per enquiry, and in most cases the advice given were assessed to have a high- or moderate clinical significance. Conclusion: The MIH was appreciated by the participants, indicating that the MIH could be a valuable service for discharged patients in improving the sense of safety in relation to medication and alleviating MRPs. Providing easy access for patients to medicine information may contribute to patient safe medicine use after discharge.
- 1 April 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (4) , 2615-2624
Drug shortages in hospitals: Actors’ perspectives
- 1 April 2022
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (4) , 2615-2624
Drug shortages in hospitals: Actors’ perspectives
- Open Access
- 5 August 2021
- Published by Elsevier in Exploratory Research in Clinical and Social Pharmacy
- Vol. 3, 100055
Prospective risk assessments of patient safety events related to drug shortages in hospitals: Three actor-level perspectives
- 5 August 2021
- Published by Elsevier in Exploratory Research in Clinical and Social Pharmacy
- Vol. 3, 100055
Open AccessProspective risk assessments of patient safety events related to drug shortages in hospitals: Three actor-level perspectives
- 1 October 2010
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 44 (13) , 808-816
Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment
- 1 October 2010
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 44 (13) , 808-816
Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment
- 1 January 2008
- Published by Elsevier in European Journal of Pharmacology
- Vol. 578 (2-3) , 114-122
Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants
- 1 January 2008
- Published by Elsevier in European Journal of Pharmacology
- Vol. 578 (2-3) , 114-122
Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants